
    
      The following specific aims are proposed:

      Aim 1: Determine whether individual patients' preferences, characteristics, and treatment
      experiences affect the definition of treatment success.

      Aim 2: Determine how to best predict real-life patients' treatment choices based on patients'
      preferences of adverse events.

      Aim 3: Determine whether physicians are likely to change their oncologic clinical practice
      after receiving a detailed communication of their patients' preferences of adverse events.
    
  